Ep145 Adrian Jones Partner HSCM Ventures: We need to reconsider the word Insurtech

November 22, 2022

Today’s guest is one of the smartest people in the insurance sector and I am really lucky to have been able to spend time talking to him fairly regularly over the course of the last few years.

I first got to know him just as the whole insurtech movement started to really take shape in around 2016 to 2017 and ever since that time he’s always been open and honest about the way he appraised the new wave of technological investment sweeping through the industry.

He never lost his critical faculties and never got caught up in the hype that defined part of that era.

But that doesn’t mean he’s a sceptic either – he’s actually quite a rare animal – an enthusiastic but realistic adopter and promoter of better ways of doing the business of insurance.

Today’s episode is one I am really pleased with because it does the job of a podcast properly. Over the years I have had many enlightening conversations with Adrian just like the one you are about to hear.

But up until now I had never recorded one.

So prepare yourself for a masterclass in what the smart money thinks about the state of insurtech. Embedded insurance, insurtech bubbles – whether they existed and whether they have now burst – how the hard reinsurance market will affect start-ups and even the very logic of the phrase insurtech itself are all addressed in the discussion.

I’ll wager you’ll get more benefit from listening to Adrian for 45 minutes than you will from attending any 3-day Insurtech conference.

LINKS
We thank our naming sponsor AdvantageGo:
https://www.advantagego.com/

TRANSCRIPT
https://www.thevoiceofinsurance.com/post/ep145-adrian-jones-transcript
——–
The views expressed are the views of Adrian Jones as of the date hereof. Hudson Structured Capital Management Ltd. (“HSCM”) undertakes no responsibility to advise you of any changes. Neither the podcast nor any of the information contained herein constitutes an offer to sell, or a solicitation of an offer to buy, any security or instrument in or to participate in any trading strategy or investment vehicle.

Past performance is not indicative of future results. There can be no assurance that any objectives can be achieved or are realistic in any given market condition.

This podcast may contain forward-looking statements; such statements are subject to various risks and uncertainties. Forward-looking statements reflect our views as of such date with respect to possible future events. Actual results could differ – perhaps materially – from those in the forward-looking statements.

The HSCM Public InsurTech Index (HPIX) tracks the price movements of a portfolio of common equity securities listed in the last 10 years by companies operating in the United States insurance sector with novel business models differentiated by technology. The HPIX components, currently 22 companies, describe themselves as having novel business models differentiated by technology. The Index components also meet certain criteria, defined in the Index Guideline (available at Solactive.com), concerning minimum size, length of public listing, geography, and certain other aspects of the business model. The chart illustrates the price movements of HPIX starting with an initial value of 100 on the first trading day of 2020.

Solactive AG (“Solactive”) is the licensor of HSCM Public InsurTech Index (the “Index”). The financial instruments that are based on the Index are not sponsored, endorsed, promoted or sold by Solactive in any way and Solactive makes no  express or implied representation, guarantee or assurance with regard to: (a) the advisability in investing in the financial instruments; (b) the quality, accuracy and/or completeness of the Index; and/or (c) the results obtained or to be obtained by any person or entity from the use of the Index. Solactive does not guarantee the accuracy and/or the completeness of the Index and shall not have any liability for any errors or omissions with respect thereto. Notwithstanding Solactive’s obligations to its licensees, Solactive reserves the right to change the methods of calculation or publication with respect to the Index and Solactive shall not be liable for any miscalculation of or any incorrect, delayed or interrupted publication with respect to the Index. Solactive shall not be liable for any damages, including, without limitation, any loss of profits or business, or any special, incidental, punitive, indirect or consequential damages suffered or incurred as a result of the use (or inability to use) of the Index.
For more information about HSCM, including risks and other disclosures, please refer to www.hscm.com.